
Helvetica Chimica Acta p. 1278 - 1284 (1998)
Update date:2022-08-03
Topics:
Kvasyuk
Kulak
Tkachenko
Sentyureva
Mikhailopulo
Suhadolnik
Heoderson
Horvath
Guan
Pfleiderer
Some new (2'-5')triadenylates 13-16, containing at the 2'-terminal end 3'-fluoro-2',3'-dideoxyadenosine derivatives, have been synthesized by the phosphotriester method. The selectively blocked nucleosides 2, 4, 5, and 7 were synthesized from the corresponding unprotected 'nucleosides 1, 3, and 6. The synthesized trimers 13 and 14 were 4- and 8-fold, respectively, more stable towards phosphodiesterase from Crotalus durissus than the natural trimer 17. In comparison to trimer 17 the new compounds 13-15 inhibit HIV-1 reverse transcriptase (RT) activity, and 15 and 16 the HIV-1 induced syncytia formation 2-3 fold whereas none of 13-16 can improve RNase L activity.
View MoreSHAANXI TOP PHARM CHEMICAL CO.LTD
Contact:+86-029-85733403
Address:No.108 ,west sector,south er huan,xi'an,china
Shanghai AoBo Bio-Pharmaceutical Technology Co., Ltd.
Contact:+86-21-51320130-801, 816
Address:Room 601, No. 1011, Halei Road, Zhangjiang High-Tech Park, Pudong, Shanghai
Kaymossy BioChem Tech Co., Ltd
website:http://www.kaimosi.com
Contact:0571-87191913/0571-87199097
Address:Room 215, Building 3rd, No.288 Ningxia Road, Qingdao city, China
Beijing Green Guardee Technology CO,.LTD
Contact:+86-10-69706062
Address:F2 BLdj,5 No.37 Chaoqian Road
Hunan Dinuo Pharmaceutical Co.,Ltd.
Contact:86-731-88280100*8561
Address:Bio-pharmaceutical industrial park, Liuyang, Hunan, China
Doi:10.1016/S0040-4039(97)01268-9
(1997)Doi:10.1016/S0040-4039(00)82415-6
(1988)Doi:10.1021/ol701583t
(2007)Doi:10.1007/s10593-014-1623-z
(2015)Doi:10.1055/s-1997-942
(1997)Doi:10.1021/jo970549p
(1997)